Direct Testing of Blood Samples to Diagnose Bloodstream Infections

Area of Science:

• Microbiology
• Molecular Diagnostics
• Infectious Diseases

Background:

• Bloodstream infection (BSI) presents a critical health challenge with high mortality rates.
• Timely and precise diagnosis of BSIs is essential for effective patient management and treatment.
• Traditional blood culture (BC) methods often exhibit limitations in speed and sensitivity, hindering prompt diagnosis.

Purpose of the Study:

• To systematically review and analyze advanced molecular diagnostic techniques for bloodstream infections.
• To evaluate the principles, benefits, and drawbacks of emerging BSI detection methods.
• To explore the potential of these technologies to transform BSI diagnostic paradigms.

Main Methods:

• Review of molecular diagnostic techniques including Raman spectroscopy, mass spectrometry, nucleic acid amplification, and hybridization assays.
• Analysis of biosensors, next-generation sequencing (NGS), CRISPR/Cas systems, digital droplet PCR (ddPCR), and T2 magnetic resonance (T2MR).
• Assessment of direct detection in whole blood, plasma, serum, and positive BC samples.

Main Results:

• Advanced molecular methods significantly reduce diagnostic time compared to conventional BC.
• These techniques enhance the identification of pathogens and antimicrobial resistance markers.
• Emerging technologies show promise for revolutionizing BSI diagnostics and patient care.

Conclusions:

• Molecular diagnostics represent a significant advancement over traditional blood cultures for BSI detection.
• These methods facilitate earlier, targeted therapeutic interventions, potentially improving patient outcomes.
• Continued research and development are crucial for optimizing these technologies for clinical application.